Madison Clarke
Hepatitis B is a liver disease caused by the hepatitis B virus (HBV). The hepatitis B vaccine is safe and effective and is recommended for all newborns, children, and adults. The vaccine is available at doctor's offices and local health departments or clinics. It typically involves a series of two or three shots, depending on the brand, and provides a lifetime of protection against HBV. While the vaccine is highly effective in preventing infection, there are cases of vaccine non-responders, who do not develop protective surface antibodies after completing the full series of vaccinations. For these individuals, it is recommended to receive a single dose of hepatitis B immunoglobulin (HBIG) and restart the hepatitis B vaccine series as soon as possible.
| Characteristics | Values |
|---|---|
| Hepatitis B vaccine effectiveness | Hepatitis B vaccines are highly effective in preventing infection. Studies indicate that immunity persists for at least 30 years among healthy people who initiate HepB vaccination at less than 6 months of age. |
| Hepatitis B vaccine dosage | The number of doses depends on the age of the recipient and the vaccine brand. People aged 19 and younger should receive three doses, while those aged 20 and older should receive three to four doses. Adults on hemodialysis should receive four doses. |
| Hepatitis B vaccine schedule | The minimum interval between the two doses of Heplisav-B is 4 weeks. For 3-dose series vaccines, the minimum interval between the first and second doses is 4 weeks, and the final dose must be administered at least 8 weeks after the second dose and at least 16 weeks after the first dose. |
| Hepatitis B vaccine non-responders | Hepatitis B vaccine "non-responders" refer to individuals who do not develop protective surface antibodies after completing two full series of the vaccine. An estimated 5-15% of people may not respond due to older age, obesity, smoking, and other chronic illnesses. |
| Recommendations for non-responders | Non-responders who test positive for hepatitis B infection should receive counseling on preventing transmission and managing their chronic infection. Those exposed to HBsAg-positive blood or body fluids should receive a single dose of hepatitis B immunoglobulin (HBIG) and restart the vaccine series as soon as possible. |
Explore related products
What You'll Learn
Hepatitis B vaccine non-responders
Hepatitis B is a liver disease caused by the hepatitis B virus (HBV). The hepatitis B vaccine is safe and effective in preventing infection and is recommended for infants, children, and adults. Each of the hepatitis B vaccines is highly effective in preventing infection, and immunity typically persists for at least 30 years.
However, a small percentage of individuals may not respond adequately to the vaccine and are considered "non-responders." Hepatitis B vaccine non-responders refer to individuals who do not develop protective surface antibodies after completing two full series of the hepatitis B vaccine and for whom an acute or chronic hepatitis B infection has been ruled out. It is estimated that approximately 5-15% of people may fall into this category due to factors such as older age, obesity, smoking, and other chronic illnesses.
For individuals who do not respond to the primary hepatitis B vaccine series, it is recommended to complete a second vaccine series or be evaluated for the presence of the hepatitis B virus (HBsAg). Testing for HBsAg is crucial before diagnosing someone as a vaccine non-responder, as it is possible that they were already infected before receiving the vaccine. If an individual tests positive for hepatitis B infection, they should receive counselling on preventing transmission and undergo regular medical care for their chronic infection.
Additionally, non-responders who have been exposed to HBsAg-positive blood or body fluids should receive hepatitis B immunoglobulin (HBIG) to prevent infection. For those who did not complete a second vaccine series, administering one dose of HBIG and restarting the vaccine series is recommended. If they have completed a second series but still failed to respond, two doses of HBIG are preferred.
It is important to note that repeat vaccination with the same dose has been shown to increase immunologic seroconversion in a significant number of previous non-responders, especially those with specific medical conditions such as HIV infection, hepatitis C virus infection, and advanced age.
Vaccines for Newborns: What's Mandatory in Minnesota?
You may want to see also
Explore related products
Hepatitis B vaccine safety
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). Hepatitis B vaccines have been available since 1982, and over 1 billion doses have been administered. The United States Food and Drug Administration (FDA) has licensed several hepatitis B vaccines, including single-antigen vaccines (Engerix-B, Heplisav-B, and Recombivax HB) and combination vaccines (Pediarix, Vaxelis, and Twinrix). These vaccines are safe and effective in preventing hepatitis B infection.
The hepatitis B vaccine is recommended for all infants, children, adolescents, and adults who have not previously been vaccinated. The Advisory Committee on Immunization Practices (ACIP) also recommends vaccination for adults aged 60 and older with risk factors for hepatitis B and those seeking protection without identified risk factors. Pregnant women and adults on haemodialysis can also safely receive the hepatitis B vaccine.
While vaccines, like any medicine, can have side effects, many people who receive the hepatitis B vaccine experience no side effects at all. The most common side effects include injection site pain, soreness, or redness, headache, and fatigue, and these are typically mild and last for 1-2 days.
The Vaccine Adverse Event Reporting System (VAERS) is a monitoring system co-managed by the CDC and FDA that collects reports of adverse events following vaccination. A review of VAERS data from 2005 to 2015 found no new or unexpected safety concerns with the hepatitis B vaccine. Additionally, scientific studies have concluded that the hepatitis B vaccine does not cause multiple sclerosis (MS) or other autoimmune conditions like diabetes and asthma. The World Health Organization (WHO), CDC, and numerous medical societies affirm that there is no confirmed evidence linking the hepatitis B vaccine to autoimmune disorders, chronic fatigue syndrome, chronic illness, rheumatoid arthritis, or any other adverse events that have been alleged.
Polio Vaccination for Babies: What US Parents Need to Know
You may want to see also
Explore related products
Hepatitis B vaccine schedule
The hepatitis B vaccine is generally administered as an injection in the arm. The vaccination schedule depends on the age of the person being vaccinated, the brand of the vaccine, and the country's national immunization program. Here is a detailed breakdown of the hepatitis B vaccine schedule for different age groups:
Infants and Newborns:
The World Health Organization (WHO) recommends that all infants receive the first dose of the hepatitis B vaccine (the "birth dose") within 24 hours of birth. This is essential for protection, as more than 90% of unvaccinated babies infected with hepatitis B will have a lifelong infection. The remaining doses are typically given at 1 month and 6 months after birth. In some cases, the first dose may be delayed until 1 month of age or hospital discharge, especially if the newborn has a birth weight of less than 2,000 grams.
Children and Adolescents:
The hepatitis B vaccine is recommended for unvaccinated children and adolescents younger than 19 years of age. The vaccination schedule for this age group typically follows a 2-dose or 3-dose series. The 2-dose series is recommended for children aged 12 months or older, with a minimum interval of 6 months between the two doses. The 3-dose series is given at 0, 1, and 6 months, with a minimum interval of 4 weeks between the first and second doses and at least 8 weeks between the second and third doses.
Adults:
Hepatitis B vaccination is recommended for adults aged 19–59 years and older individuals with risk factors for hepatitis B. The vaccination schedule for adults typically involves a 2-dose or 3-dose series. The 2-dose vaccines, such as Heplisav-B, are administered at least 4 weeks apart and are approved for adults aged 18 and older. The 3-dose vaccines, including Engerix-B, Recombivax HB, and Twinrix, are given on a schedule of 0, 1-2 months, and 6 months. The minimum interval between the first and second doses is 4 weeks, and the final dose should be administered at least 8 weeks after the second dose.
It's important to note that alternative schedules and booster doses may be considered to maximize long-term protection. Additionally, individuals with special circumstances, such as pregnancy, adult hemodialysis, or travel to endemic areas, should consult healthcare providers for specific recommendations.
Hep A and B Vaccines: Lifetime Protection?
You may want to see also
Explore related products
Hepatitis B vaccine for infants
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). People who get infected can have no symptoms, or they may experience a mild illness that feels like the flu. Some people experience fever, nausea, vomiting, and jaundice that can last for a few weeks. Hepatitis B can lead to chronic liver disease, cirrhosis, and liver cancer. The hepatitis B vaccine is safe and effective and can be given to infants, children, and adults. It is highly effective in preventing HBV infection, and studies indicate that immunity persists for at least 30 years among healthy people who initiate vaccination at less than 6 months of age.
The Advisory Committee on Immunization Practices (ACIP) recommends that all infants receive the hepatitis B vaccine at birth, regardless of the HBV infection status of the birth parent. This includes infants born to mothers with the virus in their blood, who should receive the vaccine within 12 hours of birth, along with hepatitis B immune globulin (HBIG) to provide immediate protection. The birth dose, in combination with HBIG, is 94% effective at preventing perinatal HBV transmission. For infants with low birth weights, the vaccine response can be lower, and clinicians may delay some vaccine doses. If an infant weighs less than 2,000 grams, the first vaccine dose should be administered at hospital discharge or at one month of age, whichever comes first. Overall, hepatitis B vaccination produces seroprotection in 98% of healthy term infants.
The hepatitis B vaccine is typically given as a series of two or three shots, depending on the vaccine brand. It can be administered intramuscularly into the anterolateral aspect of the thigh, and it can be given concurrently with other vaccines. The United States Food and Drug Administration (FDA) has licensed three single-antigen vaccines (Engerix-B, Heplisav-B, and Recombivax HB) and three combination vaccines (Pediarix, Vaxelis, and Twinrix) for use in the United States. People aged 19 and younger should receive three doses, while adults on hemodialysis should receive four doses.
It is important for parents to understand the risks of hepatitis B infection and the long-term effects it can have on their children. The hepatitis B virus can be spread not only through sexual contact but also via infectious blood and body fluids. Vaccinating infants at birth can prevent chronic effects later in life, as 90% of infants infected with hepatitis B will develop chronic symptoms. Properly identifying infected mothers is challenging due to potential errors in testing, interpretation, and accuracy. Therefore, administering the hepatitis B vaccine soon after birth helps minimize the risk of infection from the mother or other infected individuals in the household.
Conjugated Vaccines: The Power of Linking
You may want to see also
Explore related products
$4.95
Hepatitis B vaccine for adults
Vaccination is the best way to prevent hepatitis B infection. The hepatitis B vaccine is safe and effective for infants, children, and adults.
The World Health Organization (WHO) recommends that all infants receive the first dose of the hepatitis B vaccine within 24 hours of birth, with additional shots at 1 month and 6 months of age. Beginning the hepatitis B vaccine at birth ensures protection against hepatitis B for life. However, it is never too late to get vaccinated, and adults can still be vaccinated to protect themselves from hepatitis B infection.
The hepatitis B vaccine is typically given as a series of two or three shots, depending on the vaccine brand. The CDC recommends hepatitis B vaccination for all adults aged 19–59 and adults aged 60 and older with risk factors. Adults aged 60 and older without known risk factors may also choose to receive the hepatitis B vaccine. Adults on hemodialysis should receive four doses.
One hepatitis B vaccine, Heplisav-B, is recommended as a 2-dose series, with doses administered at least 4 weeks apart and given to adults aged 18 and older. All other hepatitis B vaccine options for adults are routinely recommended on a 3-dose schedule: 0, 1-2 months, and 6 months. Twinrix is a 4-dose vaccine that can be given on an accelerated schedule to provide protection against hepatitis A and B. Three doses are administered within 1 month, followed by a booster shot at 1 year.
It is important to note that vaccination with HEPLISAV-B may not protect all individuals. If you have a history of severe allergic reactions to any hepatitis B vaccine or its ingredients, including yeast, you should not take HEPLISAV-B. If you are immunocompromised or receiving immunosuppressant therapy, you may have a reduced immune response to HEPLISAV-B.
Vaccinated Kids: Health Risks or Rewards?
You may want to see also
Frequently asked questions
The Hepatitis B vaccine is highly effective in preventing infection. Studies indicate that immunity persists for at least 30 years among healthy people who initiate vaccination at less than 6 months of age.
The Hepatitis B vaccine is recommended for all newborns, infants, children up to 18 years, adults 19-59 years of age, and adults 60 and older with risk factors for Hepatitis B.
The number of shots depends on the brand of the vaccine. Some vaccines require two doses, while others require three or four doses. It is important to receive all doses of the vaccine to be fully protected against Hepatitis B.
